11.200 claims, may be good for a 5 billion dollar chemical giant Bayer holds heart after lost Roundup case

Economy Bayer threatens to be overloaded with miljardenclaims, now the German chemiereus a compensation of $ 80 million (71.2 million euros) must pay a very ill 70-year-old American. The man has according to the jury, cancer been given by the controversial weed killer Roundup, a pesticide produced by Monsanto, the company that the Germans last year took over.

The verdict is a painful defeat for Bayer and the chemical company or even billions of costs. The ‘case-of-80-million has been filed by Edwin Hardeman. The man was in 2015 the diagnosis of non-hodgkin's, a form of cancer that the immune system affects them. According to Hardeman, he is terminally ill, because he Roundup, for decades, used as a pesticide in his garden.

Read also the chemical Company, Bayer must cancer patient pay millions

Last week presented an American jury him in that respect in the same: his illness is indeed due to Roundup. That statement immediately resulted in a koersdreun for Bayer. The German chemicals company has lost almost 10 percent of market capitalization, a miljardenverlies. the

The last days arc the same jury over the question of whether Bayer do so can be held liable. The judges have now decided that the company with a large fee on the bridge. The main reason: the user is not sufficiently highlighted the risks to health.

Boom

Investors keep their hearts fixed: this statement may be indicative for other cases. And there are quite a few lawsuits waiting for: 11.200, to be exact. All of people who also claim to be sick and become a Roundup. The shock on the stock market today is a lot less than last week: the stock declined today, with about 1 percent, the stock is now more than 55 euro per piece, the lowest level since six years.

As we stock market analysts are to be believed, Bayer his chest, and in each case, start soaking: a number of estimates that the amount of claims up to 5 billion dollars. According to legal experts, the German chemiereus better eggs for his money, to choose and arrange. Bayer doesn't want anything to do with it. A spokesman let us know that " each case other facts and circumstances it knows. The chemical company is in appeal, and says all of the confidence in a good outcome.

first case

That will have to be demonstrated. This is not the first Rounduprechtszaak where a patient receives compensation. In the first case, brought by an American gardener who said cancer to have gotten by the way, was Monsanto in August 2018 sentenced to a compensation of the first 289 million dollars. Later, that amount has been adjusted downward to $ 80 million. Possible, there is still a different amount roll-out; also in this case there is an appeal.

anyway, the Roundup begins where hoofdpijndossier to be for Bayer. Since Bayer zaadveredelaar Monsanto, and that Roundup produces, last year to 62 billion dollars took over, the company has 60 percent of its market value is lost. Roundup, glyphosate as the main active ingredient. Meanwhile, the patent expired and are all variants of to purchase.

“Not a carcinogen”

Although there is much controversy and protests, decided to Europe for a permit for the controversial weed killer by a further five year extension. That authorisation was issued, partly after the European data protection supervisor to the judgment was that the substance is not a carcinogen. Health organization WHO came earlier to a different opinion: glyphosate is likely, however, is a carcinogen.